Cadila Healthcare informs about updates on board meeting

30 Apr 2016 Evaluate

With reference to the earlier letter dated April 25, 2016, Cadila Healthcare has now informed that the Board of Directors at its meeting to be held on May 13, 2016, to raise funds by issue of Equity Shares / convertible Bonds / Debentures through Qualified Institutional Placement [QIP] / GDR / ADR for an aggregate amount up to Rs 10,000 Crores, to issue Secured / Unsecured Redeemable Non-Convertible Debentures on private placement basis for an amount up to Rs 3500 Crores in the Financial Year 2016-17, and to issue Secured / Unsecured Foreign Currency Rated Bonds / Foreign Currency Convertible Bonds for an amount up to Rs 5000 Crores for raising funds / issuance of securities, which will be subject to approval of the members.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

881.10 13.30 (1.53%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×